However, there might be significant differences for severe COVID-19 among cancer patients regarding underlying tumor (i.e., primary tumor site, stage of disease), and type of systemic treatment (i.e., chemotherapy, immunotherapy, targeted therapy) [ 18 , 19 ].
1
—
—